HCWB (STOCKS)
HCW Biologics Inc. Common Stock
$1.229100
-0.050900 (-3.98%)
Prev close: $1.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Hing C. Wong
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.88M
- Employees
- 36
- P/E (TTM)
- -0.13
- P/B (TTM)
- 1.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.37 | $-0.45 | +0.8188 | +182.44% |
|
Dec 2025 (Q4)
|
$-3.19 | $-0.86 | -2.3332 | -272.32% |
|
Sep 2025 (Q3)
|
$-2.02 | $-2.35 | +0.3260 | +13.90% |
|
Jun 2025 (Q2)
|
$-1.08 | $1.84 | -2.9160 | -158.82% |
Financial Statements
| Revenues | $6.55M |
| Benefits Costs and Expenses | $10.71M |
| Cost Of Revenue | $50.41K |
| Costs And Expenses | $8.76M |
| Gross Profit | $6.54M |
| Operating Expenses | $14.52M |
| Research and Development | $5.22M |
| Other Operating Expenses | $9.30M |
| Operating Income/Loss | -$7.98M |
| Income/Loss From Continuing Operations After Tax | -$1.96M |
| Income/Loss From Continuing Operations Before Tax | -$6.10M |
| Interest Expense, Operating | $677.19K |
| Net Income/Loss | -$2.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.67M |
| Preferred Stock Dividends And Other Adjustments | $5.67M |
| Basic Earnings Per Share | -$7.73 |
| Diluted Earnings Per Share | -$7.73 |
| Basic Average Shares | 9,902,421 |
| Diluted Average Shares | 9,902,421 |
| Assets | $27.34M |
| Current Assets | $1.72M |
| Accounts Receivable | $74.84K |
| Prepaid Expenses | $297.76K |
| Other Current Assets | $1.35M |
| Noncurrent Assets | $25.62M |
| Fixed Assets | $20.77M |
| Other Non-current Assets | $4.85M |
| Liabilities | $21.58M |
| Current Liabilities | $19.96M |
| Accounts Payable | $11.79M |
| Other Current Liabilities | $8.17M |
| Noncurrent Liabilities | $1.62M |
| Equity | $5.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.76M |
| Liabilities And Equity | $27.34M |
| Net Cash Flow From Operating Activities | -$11.45M |
| Net Cash Flow From Operating Activities, Continuing | -$11.45M |
| Net Cash Flow From Investing Activities | -$121.27K |
| Net Cash Flow From Investing Activities, Continuing | -$121.27K |
| Net Cash Flow From Financing Activities | $11.57M |
| Net Cash Flow From Financing Activities, Continuing | $11.57M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$2.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.29M |
| Other Comprehensive Income/Loss | $0.00 |